Concepts (104)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Shock, Septic | 3 | 2023 | 105 | 1.020 |
Why?
|
| Early Ambulation | 3 | 2023 | 25 | 1.020 |
Why?
|
| Intensive Care Units | 5 | 2023 | 397 | 0.810 |
Why?
|
| Respiration, Artificial | 2 | 2022 | 351 | 0.680 |
Why?
|
| Vasoconstrictor Agents | 1 | 2018 | 56 | 0.610 |
Why?
|
| Muscle Weakness | 1 | 2018 | 61 | 0.610 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2016 | 25 | 0.520 |
Why?
|
| Hemorrhage | 1 | 2016 | 284 | 0.450 |
Why?
|
| Critical Care | 3 | 2021 | 384 | 0.380 |
Why?
|
| Cytokines | 3 | 2023 | 806 | 0.330 |
Why?
|
| Physical Therapy Modalities | 2 | 2021 | 84 | 0.330 |
Why?
|
| Sepsis | 2 | 2025 | 326 | 0.320 |
Why?
|
| Noninvasive Ventilation | 2 | 2018 | 24 | 0.280 |
Why?
|
| Enterobactin | 1 | 2025 | 5 | 0.250 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2025 | 20 | 0.240 |
Why?
|
| Immunity | 2 | 2022 | 141 | 0.220 |
Why?
|
| Diaphragm | 1 | 2022 | 50 | 0.200 |
Why?
|
| Respiratory Dead Space | 1 | 2021 | 3 | 0.200 |
Why?
|
| Macrophages | 1 | 2025 | 578 | 0.190 |
Why?
|
| Pneumonia | 1 | 2022 | 183 | 0.180 |
Why?
|
| Length of Stay | 3 | 2021 | 743 | 0.180 |
Why?
|
| Respiratory Insufficiency | 1 | 2022 | 161 | 0.180 |
Why?
|
| Carbon Dioxide | 1 | 2021 | 201 | 0.180 |
Why?
|
| Statistics as Topic | 1 | 2021 | 234 | 0.180 |
Why?
|
| Body Temperature | 1 | 2020 | 125 | 0.180 |
Why?
|
| Cognitive Dysfunction | 1 | 2023 | 153 | 0.180 |
Why?
|
| Head Protective Devices | 2 | 2018 | 20 | 0.170 |
Why?
|
| Mice, Knockout | 1 | 2025 | 2014 | 0.170 |
Why?
|
| DNA, Bacterial | 1 | 2020 | 244 | 0.160 |
Why?
|
| Humans | 16 | 2023 | 89613 | 0.160 |
Why?
|
| Occupational Therapy | 1 | 2018 | 16 | 0.160 |
Why?
|
| Muscle Strength | 1 | 2018 | 30 | 0.160 |
Why?
|
| Laryngeal Masks | 1 | 2018 | 12 | 0.150 |
Why?
|
| Lidocaine | 1 | 2018 | 65 | 0.150 |
Why?
|
| Critical Illness | 2 | 2023 | 307 | 0.150 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2025 | 516 | 0.150 |
Why?
|
| Intubation | 1 | 2017 | 21 | 0.150 |
Why?
|
| Anesthetics, Local | 1 | 2018 | 76 | 0.150 |
Why?
|
| Disease Models, Animal | 1 | 2025 | 2384 | 0.150 |
Why?
|
| Prospective Studies | 2 | 2023 | 4309 | 0.150 |
Why?
|
| Lung Injury | 1 | 2017 | 53 | 0.140 |
Why?
|
| Thoracic Diseases | 1 | 2016 | 27 | 0.130 |
Why?
|
| Masks | 1 | 2016 | 29 | 0.130 |
Why?
|
| Risk Adjustment | 1 | 2016 | 38 | 0.130 |
Why?
|
| Pain | 1 | 2018 | 399 | 0.130 |
Why?
|
| Emergencies | 1 | 2016 | 122 | 0.130 |
Why?
|
| Education, Medical, Continuing | 1 | 2016 | 105 | 0.120 |
Why?
|
| Intubation, Intratracheal | 1 | 2016 | 147 | 0.120 |
Why?
|
| Adult | 6 | 2023 | 26704 | 0.110 |
Why?
|
| Aged | 6 | 2021 | 19158 | 0.110 |
Why?
|
| Middle Aged | 7 | 2021 | 26012 | 0.110 |
Why?
|
| Emergency Medical Services | 1 | 2016 | 242 | 0.110 |
Why?
|
| United States | 2 | 2023 | 7050 | 0.100 |
Why?
|
| Curriculum | 1 | 2016 | 571 | 0.090 |
Why?
|
| Male | 8 | 2023 | 42488 | 0.090 |
Why?
|
| Female | 8 | 2023 | 46401 | 0.090 |
Why?
|
| Risk Factors | 1 | 2016 | 5517 | 0.060 |
Why?
|
| Cecum | 1 | 2025 | 73 | 0.060 |
Why?
|
| Tryptophan | 1 | 2025 | 97 | 0.060 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2025 | 69 | 0.060 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2025 | 175 | 0.050 |
Why?
|
| Bile Acids and Salts | 1 | 2022 | 67 | 0.050 |
Why?
|
| Atrophy | 1 | 2022 | 122 | 0.050 |
Why?
|
| Validation Studies as Topic | 1 | 2021 | 17 | 0.050 |
Why?
|
| Hypnotics and Sedatives | 1 | 2022 | 132 | 0.050 |
Why?
|
| Bacterial Load | 1 | 2020 | 19 | 0.040 |
Why?
|
| beta-Lactam Resistance | 1 | 2020 | 11 | 0.040 |
Why?
|
| Gram-Negative Bacteria | 1 | 2020 | 35 | 0.040 |
Why?
|
| Gram-Positive Bacteria | 1 | 2020 | 18 | 0.040 |
Why?
|
| Multiplex Polymerase Chain Reaction | 1 | 2020 | 35 | 0.040 |
Why?
|
| Decision Trees | 1 | 2020 | 59 | 0.040 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2020 | 127 | 0.040 |
Why?
|
| Fever | 1 | 2020 | 127 | 0.040 |
Why?
|
| Bacteremia | 1 | 2020 | 102 | 0.040 |
Why?
|
| Genes, Bacterial | 1 | 2020 | 198 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2025 | 795 | 0.040 |
Why?
|
| ROC Curve | 1 | 2021 | 776 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2020 | 260 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2021 | 782 | 0.040 |
Why?
|
| Pain Perception | 1 | 2018 | 18 | 0.040 |
Why?
|
| Injections, Subcutaneous | 1 | 2018 | 121 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2023 | 8218 | 0.040 |
Why?
|
| Staphylococcal Infections | 1 | 2020 | 271 | 0.040 |
Why?
|
| Logistic Models | 1 | 2021 | 1214 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2025 | 3240 | 0.040 |
Why?
|
| Point-of-Care Systems | 1 | 2018 | 145 | 0.040 |
Why?
|
| Chicago | 1 | 2021 | 1430 | 0.030 |
Why?
|
| Early Termination of Clinical Trials | 1 | 2016 | 13 | 0.030 |
Why?
|
| Pain Measurement | 1 | 2018 | 332 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2020 | 699 | 0.030 |
Why?
|
| Skin Ulcer | 1 | 2016 | 25 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1862 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 2016 | 0.030 |
Why?
|
| Self-Injurious Behavior | 1 | 2017 | 111 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2021 | 2878 | 0.030 |
Why?
|
| Quality of Life | 1 | 2023 | 1673 | 0.030 |
Why?
|
| Biomarkers | 1 | 2020 | 1768 | 0.030 |
Why?
|
| Prognosis | 1 | 2020 | 3785 | 0.030 |
Why?
|
| Asthma | 1 | 2020 | 983 | 0.020 |
Why?
|
| Mice | 1 | 2025 | 11832 | 0.020 |
Why?
|
| Adolescent | 1 | 2023 | 9305 | 0.020 |
Why?
|
| Time Factors | 1 | 2016 | 5337 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2021 | 9127 | 0.020 |
Why?
|
| Animals | 1 | 2025 | 27481 | 0.020 |
Why?
|